Patient Guide: Study to Evaluate Adverse Events, and Change in Disease Activity, When Intravenously (IV) Infused With Livmoniplimab in Combination With IV Infused Budigalimab in Adult Participants With Hepatocellular Carcinoma (HCC)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 59 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05822752
Status: ACTIVE_NOT_RECRUITING
Condition: Hepatocellular Carcinoma
Phase: PHASE2

Where You Can Participate

This study is available at 59 locations across the country.

Top locations include:
  • • Prescott Valley, Arizona
  • • Springdale, Arkansas
  • • Los Angeles, California
  • • And 56 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Study to Evaluate Adverse Events, and Change in Disease Activity, When Intravenously (IV) Infused With Livmoniplimab in Combination With IV Infused Budigalimab in Adult Participants With Hepatocellular Carcinoma (HCC) - Join Clinical Trial NCTNCT05822752

How to Join This Clinical Trial - NCTNCT05822752

Learn how to participate in this PHASE2 trial studying an investigational therapy for Hepatocellular Carcinoma. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Hepatocellular Carcinoma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Hepatocellular Carcinoma
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT05822752 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 59 locations. Find a study site near you:

Clinical Research Site

Prescott Valley, Arizona 86314 - United States

Status: Contact for availability

Clinical Research Site

Springdale, Arkansas 72762 - United States

Status: Contact for availability

Clinical Research Site

Los Angeles, California 90095 - United States

Status: Contact for availability

Clinical Research Site

Orange, California 92868 - United States

Status: Contact for availability

Clinical Research Site

San Francisco, California 94115 - United States

Status: Contact for availability

Clinical Research Site

Denver, Colorado 80218 - United States

Status: Contact for availability

Clinical Research Site

Orlando, Florida 32803 - United States

Status: Contact for availability

Clinical Research Site

Chicago, Illinois 60637-1443 - United States

Status: Contact for availability

Clinical Research Site

Baton Rouge, Louisiana 70809 - United States

Status: Contact for availability

Clinical Research Site

Boston, Massachusetts 02215 - United States

Status: Contact for availability

And 49 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Hepatocellular Carcinoma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships